ITCI   $131.87  -0.04% Market Closed

Intra-Cellular Therapies Inc.
Total Cash 1.01B
totalCashPerShare 9.494
EBITDA -121.09M
Total Debt 17.71M
quickRatio 6.936
currentRatio 7.656
Total Revenue 613.73M
debtToEquity 1.547
Revenue/Share 6.096
ROA -0.07445
ROE -0.09896
grossProfits
freeCashflow -6.95M
operatingCashflow -62.16M
earningsGrowth
revenueGrowth 0.39
grossMargins 0.57006
ebitdaMargins -0.1973
operatingMargins -0.22152
profitMargins -0.14073
enterpriseValue 8.47B
forwardPE 185.91667
floatShares 103.74M
sharesOutstanding 106.02M
sharesShort 2.42M
sharesShortPriorMonth 2.57M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.97%
Short Ratio help_outline 5.10%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 10.8
Price To Book help_outline 8.26
earningsQuarterlyGrowth
netIncomeToCommon -86.37M
trailingEps -0.87%
forwardEps 0.48%
enterpriseToEbitda -69.97
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.11 4Q 2024
institutionsCount 512
lastUpdated Nov. 6, 2024, 5:24 p.m.